|
|||||||||||||
|
Insulin secretagogues peptides (incretins) in Diabetes - Clinical Trial ResultsSystematic review and meta-analysis of clinical trials about insulin secretagogues peptides (incretins) in diabetes. Clinical trials enrolled the following type of patients : See also:
Entry term : Glucose Intolerance, Diabetes Mellitus, Insulin Dependent, Type 1 Diabetes Mellitus, IDDM, Diabetes Mellitus, Type 2, Diabetes Mellitus, Non Insulin Dependent, Type 2 Diabetes Mellitus, NIDDM, diabetic, Incretin, Glucose-Dependent Insulin-Releasing Hormone, Glucagon-Like Peptide 1 agonists, GLP-1 agonists, GLP 1 agonists, |
||||||||||||
|